In the last trading session, 1.14 million Lucid Diagnostics Inc (NASDAQ:LUCD) shares changed hands as the company’s beta touched 1.31. With the company’s per share price at $1.30 changed hands at $0.0 or 0.00% during last session, the market valuation stood at $140.65M. LUCD’s last price was a discount, traded about -38.46% off its 52-week high of $1.80. The share price had its 52-week low at $0.68, which suggests the last value was 47.69% up since then.
Analysts gave the Lucid Diagnostics Inc (LUCD) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 1 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended LUCD as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.
Lucid Diagnostics Inc (NASDAQ:LUCD) trade information
The company’s shares are showing year-to-date upside of 58.79%, with the 5-day performance at 3.17% in the green. However, in the 30-day time frame, Lucid Diagnostics Inc (NASDAQ:LUCD) is 15.04% up.
The consensus price target for the stock as assigned by Wall Street analysts is 2, meaning bulls need an upside of 35.0% from its current market value. According to analyst projections, LUCD’s forecast low is 2 with 2 as the target high. To hit the forecast high, the stock’s price needs a -53.85% plunge from its current level, while the stock would need to soar -53.85% for it to hit the projected low.
Lucid Diagnostics Inc (LUCD) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -54.43%. The 2025 estimates are for Lucid Diagnostics Inc earnings to increase by 31.90%, but the outlook for the next 5-year period is at 37.27% per year.
Lucid Diagnostics Inc (NASDAQ:LUCD)’s Major holders
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 1.2461% or 0.56 million shares worth $0.46 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund. With 612.6 shares estimated at $0.8 million under it, the former controlled 0.57% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.26% of the shares, roughly 276.27 shares worth around $0.36 million.
